Results 161 to 170 of about 879,101 (311)

Autologous bone marrow transplantation in non-Hodgkin lymphoma patients following different conditioning regimens: an 11-year single-center quasi-experimental study. [PDF]

open access: yesBlood Res
Tavakoli Shiraji S   +9 more
europepmc   +1 more source

Visionary Leadership in Cancer Care: An Interview With Professor Timothy J. Eberlein

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
Professor Timothy J. Eberlein and Professor Ken Shirabe, President of the Japanese Society of Gastroenterological Surgery, during their interview discussing the vision, strategic framework, and leadership that shaped the development of the Siteman Cancer Center into a world‐class institution. ABSTRACT This is a short interview with Professor Timothy J.
Ken Shirabe   +3 more
wiley   +1 more source

Angiocentric T-cell lymphoma in a cat. [PDF]

open access: yesJ Vet Diagn Invest
Krebs KH   +3 more
europepmc   +1 more source

The Impact of Anticoagulation in Patients With Isolated Cancer‐Associated Splanchnic Vein Thrombosis: A Dual‐Center Cohort Study

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Data to guide management of isolated bland cancer‐associated splanchnic vein thrombosis (CA‐SpVT) are limited. We aimed to assess the role of anticoagulation (AC) and bleeding and thrombosis in patients with CA‐SpVT. We conducted a dual‐center retrospective cohort study of adults with incident, isolated, bland CA‐SpVT from 2011 to 2020.
Abhilasha Borad   +9 more
wiley   +1 more source

Advancing the Diagnosis of Non-Hodgkin Lymphoma Through Next-Generation Sequencing in Developing Countries: An Evaluation of Progress-A Narrative Review. [PDF]

open access: yesHealth Sci Rep
Saeidnia M   +8 more
europepmc   +1 more source

High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Soluble tumor necrosis factor receptor 2 (sTNFR2) is a member of the TNF superfamily whose normal bodily distribution is largely limited to low level expression on lymphoid cells. It has emerged as an important inducible receptor that activates a signaling pathway for cancer growth.
Arushi Khurana   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy